X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (62) 62
index medicus (49) 49
endocrinology & metabolism (43) 43
male (41) 41
middle aged (37) 37
aged (33) 33
postmenopausal women (26) 26
female (25) 25
osteoporosis (24) 24
abridged index medicus (21) 21
adult (21) 21
bone density - drug effects (20) 20
bone-mineral density (18) 18
denosumab (18) 18
testosterone - blood (15) 15
teriparatide (14) 14
bone density conservation agents - therapeutic use (13) 13
parathyroid-hormone (13) 13
article (12) 12
osteoporosis, postmenopausal - drug therapy (12) 12
treatment outcome (12) 12
aged, 80 and over (11) 11
bone density (11) 11
fractures (11) 11
parathyroid hormone (11) 11
peptides - blood (11) 11
alendronate (10) 10
analysis (10) 10
density (10) 10
estradiol - blood (10) 10
prevention (10) 10
teriparatide - therapeutic use (10) 10
animals (9) 9
bone density conservation agents - administration & dosage (9) 9
bone remodeling - drug effects (9) 9
collagen type i - blood (9) 9
original (9) 9
osteoporosis - drug therapy (9) 9
teriparatide - administration & dosage (9) 9
bone and bones - drug effects (8) 8
double-blind method (8) 8
history (8) 8
randomized controlled-trial (8) 8
risk (8) 8
biomarkers - blood (7) 7
bone density conservation agents - adverse effects (7) 7
bone mineral density (7) 7
bones (7) 7
clinical trials (7) 7
men (7) 7
physiological aspects (7) 7
research (7) 7
therapy (7) 7
vertebral fractures (7) 7
young adult (7) 7
zoledronic acid (7) 7
care and treatment (6) 6
combination therapy (6) 6
drug therapy (6) 6
drug therapy, combination (6) 6
medicine, general & internal (6) 6
mineral density (6) 6
older men (6) 6
procollagen - blood (6) 6
risk factors (6) 6
teriparatide - adverse effects (6) 6
teriparatide - pharmacology (6) 6
testosterone (6) 6
androgens (5) 5
antibodies, monoclonal, humanized - administration & dosage (5) 5
bone and bones - metabolism (5) 5
bone density conservation agents - pharmacology (5) 5
calcium - blood (5) 5
cancer (5) 5
elderly-men (5) 5
follow-up studies (5) 5
fracture risk (5) 5
health aspects (5) 5
hypogonadal men (5) 5
medical research (5) 5
multivariate analysis (5) 5
original article (5) 5
peptide fragments - blood (5) 5
prostate cancer (5) 5
tumors (5) 5
united states (5) 5
absorptiometry, photon (4) 4
alendronate - administration & dosage (4) 4
alendronate - therapeutic use (4) 4
antibodies, monoclonal, humanized - therapeutic use (4) 4
biochemical markers (4) 4
biochemistry & molecular biology (4) 4
cross-sectional studies (4) 4
denosumab - therapeutic use (4) 4
dietary phosphate (4) 4
diphosphonates - therapeutic use (4) 4
dose-response relationship, drug (4) 4
estrogen plus progestin (4) 4
fibroblast growth factor-23 (4) 4
fibroblast growth factors - blood (4) 4
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (4) 4
UTL at Downsview - May be requested (4) 4
Gerstein Science - Stacks (3) 3
St. Michael's College (John M. Kelly) - 2nd Floor (2) 2
UofT at Mississauga - Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Music - Stacks (1) 1
OISE - Stacks (1) 1
Toronto East General Hospital - Stacks (1) 1
Trinity College (John W Graham) - Storage (1) 1
UofT at Scarborough - Stacks (1) 1
Victoria University E.J. Pratt - Stacks (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Bone and Mineral Research, ISSN 0884-0431, 10/2019
Journal Article
Journal of Bone and Mineral Research, ISSN 0884-0431, 05/2019, Volume 34, Issue 5, pp. 976 - 976
Journal Article
The Journal of Clinical Endocrinology & Metabolism, ISSN 0021-972X, 11/2019
Abstract Context The ACTIVE study demonstrated the antifracture efficacy of abaloparatide in postmenopausal women with osteoporosis. ACTIVExtend demonstrated... 
Journal Article
The Journal of Clinical Endocrinology & Metabolism, ISSN 0021-972X, 11/2019
Abstract Context In the DATA-HD study, we reported that 15-months of combined high-dose (HD) teriparatide and denosumab increased mean areal bone mineral... 
Journal Article
Journal of Bone and Mineral Research, ISSN 0884-0431, 09/2019, Volume 34, Issue 9, pp. 1549 - 1551
ABSTRACT The public health implications of osteoporosis are enormous but the disease remains underdiagnosed and undertreated. In October 2018, the National... 
FRACTURE PREVENTION | OSTEOPOROSIS DRUG THERAPY | OSTEOPOROSIS | Prevention | Osteoporosis | Fractures | Drug therapy | Public health
Journal Article
The Journal of Clinical Endocrinology & Metabolism, ISSN 0021-972X, 07/2019, Volume 104, Issue 11, pp. 5611 - 5620
Teriparatide and denosumab are effective treatments for osteoporosis and typically reserved as second-line options after patients have used bisphosphonates.... 
Journal Article
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, ISSN 0884-0431, 09/2019, Volume 34, Issue 9, pp. 1549 - 1551
The public health implications of osteoporosis are enormous but the disease remains underdiagnosed and undertreated. In October 2018, the National Institutes... 
UNITED-STATES | OSTEOPOROSIS DRUG THERAPY | REDUCTION | FRACTURE PREVENTION | ENDOCRINOLOGY & METABOLISM | RISK | TERIPARATIDE | OSTEOPOROSIS | Prevention | Drug therapy | Osteoporosis
Journal Article
Journal of Bone and Mineral Research, ISSN 0884-0431, 02/2018, Volume 33, Issue 2, pp. 188 - 189
Journal Article
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, ISSN 0884-0431, 08/2019
In the randomized, placebo-controlled, double-blind phase 3 ACTIVE study (NCT01343004), 18 months of abaloparatide 80 μg daily (subcutaneous injection) in... 
Journal Article
The Lancet Diabetes & Endocrinology, ISSN 2213-8587, 10/2019, Volume 7, Issue 10, pp. 767 - 775
In the Denosumab and Teriparatide Administration (DATA) study, we showed that denosumab fully inhibits teriparatide-induced bone resorption while allowing for... 
CORTICAL BONE | HIP FRACTURE | ESTIMATED STRENGTH | BONE-MINERAL DENSITY | VERTEBRAL FRACTURES | YEARLY ZOLEDRONIC ACID | ENDOCRINOLOGY & METABOLISM | PARATHYROID-HORMONE | QUANTITATIVE COMPUTED-TOMOGRAPHY | FRACTURE RISK | FINITE-ELEMENT-ANALYSIS
Journal Article
Journal of Bone and Mineral Research, ISSN 0884-0431, 10/2017, Volume 32, Issue 10, pp. 2001 - 2009
Journal Article
The Journal of Clinical Endocrinology & Metabolism, ISSN 0021-972X, 06/2013, Volume 98, Issue 6, pp. 39A - 40A
Journal Article
Journal Article
Journal Article
The Journal of Clinical Endocrinology & Metabolism, ISSN 0021-972X, 02/2012, Volume 97, Issue 2, pp. 36A - 36A
Journal Article
Journal of Bone and Mineral Research, ISSN 0884-0431, 06/2014, Volume 29, Issue 6, pp. 1380 - 1386
Journal Article
The American Journal of Clinical Nutrition, ISSN 0002-9165, 08/2015, Volume 102, Issue 2, p. 385
  Epidemiologic data suggest that low serum 25-hydroxyvitamin D [25(OH)D] increases insulin resistance and the risk of type 2 diabetes. Few interventional... 
Sensitivity analysis | Vitamin D | Clinical trials | Adults | Epidemiology | Insulin
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.